# Sterling Knight Pharmaceuticals, LLC – FDA Inspection, Apr 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/sterling-knight-pharmaceuticals-llc/886d47b4-7bdc-43cc-ae06-274a4209e7ca
Source feed: FDA_Inspections

> FDA inspection 1085950 of Sterling Knight Pharmaceuticals, LLC, April 11, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085950
- Company Name: Sterling Knight Pharmaceuticals, LLC
- Inspection Date: 2019-04-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 949854 - 2015-11-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)

Company: https://www.keypedia.com/companies/sterling-knight-pharmaceuticals-llc/dadb3e3e-5edd-4df1-a365-2578a60cdd0c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c